Sec Form 13D Filing - William Snider filing for - 2026-03-23

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D



Comment for Type of Reporting Person:
Note to Rows 7, 9, and 11: Consists of 21,000 shares of Harvard Bioscience, Inc. (the "Issuer") common stock, par value $0.01 per share ("Common Stock") held by William Snider. Note to Rows 8, 10 and 11: Consists of (i) 60,000 shares of Common Stock issuable upon the exercise of warrants held by BroadOak Income Fund, L.P. ("BroadOak Income Fund"); (ii) 15,000 shares of Common Stock issuable upon the exercise of the warrants held by BroadOak Fund VI, L.P. ("BroadOak Fund VI"); and (iii) 750,000 shares of Common Stock issuable upon the conversion of the convertible loan held by BroadOak Income Fund. BroadOak Capital Partners, LLC ("BroadOak Capital Partners") is the parent of BroadOak Income Fund and BroadOak Fund VI (collectively, the "BroadOak Funds"), and as such may be deemed to share beneficial ownership of the shares of Common Stock underlying the warrants and convertible loan held by the BroadOak Funds. William Snider has sole voting and dispositive power over the shares of common stock underlying the warrants and convertible loan held by the BroadOak Funds, and as such may be deemed to share beneficial ownership of such shares. The number of shares held by the Reporting Persons as disclosed in this filing reflects the 10:1 reverse stock split of the Common Stock effected by the Issuer on March 13, 2026 (the "Stock Split"). Note to Row 13: Based on (i) 4,471,989 shares of Common Stock outstanding as of March 5, 2026, as reported in the Issuer's Form 10-K filed with the U.S. Securities and Exchange Commission (the "SEC") on March 13, 2026, as adjusted to reflect the Stock Split, and (ii) assumes the issuance of shares of Common Stock underlying the warrants and convertible loans held by the BroadOak Funds in the following amounts, as adjusted to reflect the Stock Split: with respect to (A) BroadOak Income Fund, 810,000 shares; (B) BroadOak Fund VI, 15,000 shares; and (C) BroadOak Capital Partners and Mr. Snider, 825,000 shares.


SCHEDULE 13D

 
BroadOak Income Fund, L.P.
 
Signature:/s/ William Snider
Name/Title:William Snider, Manager
Date: 03/23/2026
 
BroadOak Fund VI, L.P.
 
Signature:/s/ William Snider
Name/Title:William Snider, Manager
Date:03/23/2026
 
BroadOak Capital Partners, LLC
 
Signature:/s/ William Snider
Name/Title:William Snider, Partner
Date:03/23/2026
 
William Snider
 
Signature:/s/ William Snider
Name/Title:William Snider
Date:03/23/2026
primary_doc.xml